Skip to main content

United States News All stories

Every story in this section, newest first — page 216 of 373.

Grafa

Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness

Moderna (NASDAQ:MRNA) announced a significant milestone in global health security on April 22, 2026, with the dosing of the first participants in the United States and the United Kingdom for its Phase 3 clinical trial of mRNA-1018.

Read more: Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness
Grafa
Technology

Kemper sells Newins distribution operation to Confie to sharpen specialty focus

Kemper (NYSE:KMPR) announced today that it has completed the sale of its property and casualty distribution operation, which includes captive agents and storefront locations, to Confie, a leading national insurance distribution company.

Read more: Kemper sells Newins distribution operation to Confie to sharpen specialty focus